TABLE 1.
Demographic background of the sample
| Measure | ALSni | ALSci | ALSbi | ALScbi | ALS‐FTD |
|---|---|---|---|---|---|
| N (%) | 33 (40%) | 12 (14%) | 26 (31%) | 8 (10%) | 4 (5%) |
| Sex (f/m) | 11/22*** | 3/9*** | 8/18*** | 2/6*** | 1/3*** |
| Age | 59.27 (13.77) | 60.25 (11.74)* | 62.00 (10.87) | 61.63 (12.18)* | 67.25 (7.63) |
| Education (Years) | 12.88 (2.25) | 12.25 (1.66) | 13.12 (2.29)* | 12.25 (2.19) | 12.50 (2.65) |
| Premorbid IQ | 101.77 (8.71) | 91.20 (7.10)† | 100.19 (10.42)* | 97.83 (9.68) | 97.67 (21.22) |
| ALSFRS‐R | 37.66 (6.95) | 37.50 (4.80)* | 35.96 (8.44) | 36.38 (8.44) | 37.25 (10.47) |
| Disease duration (Months) | 24.33 (19.49) | 20.92 (14.93)* | 27.08 (25.69)* | 31.38 (23.22) | 20.00 (11.40) |
| ALSFRS‐R δ | 0.64 (0.47) | 0.86 (0.86) | 0.89 (1.10) | 1.03 (1.18) | 0.49 (0.24) |
*
BF01 > 3, moderate evidence of no differences to ALSni;
**
BF01 > 30, very strong evidence of no differences to ALSni;
***
BF01 > 100, extremely strong evidence of no between‐group differences in sex distribution.
†
BF10 > 3, moderate evidence of a difference to ALSni.